DIKER MANAGEMENT LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1276525 New York, NY

Position in SPRY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$269,069

-$121,299 QoQ

Shares Held

33,508

0.0% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

DIKER MANAGEMENT LLC holds $482,119 across 4 Biotechnology names. SPRY ranks #1 (55.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SPRY	ARS Pharmaceuticals, Inc. This page	33,508	$269,069
2	VNDA	Vanda Pharmaceuticals Inc.	21,880	$151,190
3	LXRX	Lexicon Pharmaceuticals, Inc.	20,000	$31,200
4	JSPR	Jasper Therapeutics, Inc.	35,000	$30,660

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$269,069	33,508	0.0%	Shares	Sole	2026-05-15
2025-12-31	$390,368	33,508	-23.0%	Shares	Sole	2026-02-17
2025-09-30	$437,255	43,508	+6.1%	Shares	Sole	2025-11-14
2025-06-30	$715,450	41,000	+95.2%	Shares	Sole	2025-08-14
2025-03-31	$264,180	21,000	—	Shares	Sole	2025-05-22
No filing history on record for this holder in this stock.